v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Expenses      
Research and Development $ (5,229) $ (8,113) $ (12,955)
Operating expenses (10,565) (9,871) (1,631)
Total operating expenses (15,794) (17,984) (14,586)
Loss from operations (15,794) (17,984) (14,586)
Other income/(expense):      
Finance (expense)/ income 814 1,144 (7)
FV Loss on Investment (1,766) (402) (869)
Other income/(losses) 65
Total other income/(expense) (952) 742 (811)
Loss from operations before income taxes (16,746) (17,242) (15,397)
Income tax (expense)/credit 4,883 (449)
Loss for the year (11,863) (17,691) (15,397)
Other Comprehensive loss:      
Gain/(Loss) on currency translation (72) 1,492 (3,582)
Comprehensive loss $ (11,935) $ (16,199) $ (18,979)
Basic loss per share attributable to common shareholders (in Dollars per share) $ (0.11) $ (0.17) $ (0.15)
Diluted loss per share attributable to common shareholders (in Dollars per share) $ (0.11) $ (0.17) $ (0.15)